EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Applications of macrocyclic molecules in cancer therapy: Target cancer development or overcome drug resistance

Xiaoling Song, Yifan Wu, Xiaojuan Qu, Biao Jiang

MedComm – Oncology · 2023-09 · 2 (3)

DOI: 10.1002/mog2.50 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm – Oncology, online erschienen am 04.09.2023. Verfasst von Xiaoling Song und 3 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific and Innovative Action Plan of Shanghai, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a worldwide leading cause of cancer‐related death due to a lack of efficient disease control by drugs. With the increasing unmet needs in cancer treatment, developing novel effective cancer drugs is in great demand. Macrocyclic molecules represent a group of drug molecules with a cyclic skeleton which endows them with unique drug properties such as improved bioavailability, enhanced metabolic stability, increased binding affinity, and favorable pharmacokinetics parameters. The Food and Drug Administration (FDA) has approved a bunch of macrocyclic drugs to treat cancer patients. However, the importance of such molecules in cancer drug development remains underestimated. Recent studies support that macrocyclic molecules can also serve as an effective strategy to overcome drug resistance in cancer treatment, but is a lack of review. The purpose of this manuscript was to provide shreds of evidence on the applications of macrocyclic molecules for cancer therapy: (1) act as cancer drugs to target different proteins critical for cancer development; (2) act as cancer drugs to target resistant mutants of oncogenes to overcome drug resistance in targeted therapy. This review will help to attract more interest in developing macrocyclic drugs for cancer therapy and potentially provide more novel strategies to benefit cancer patients and society.

Förderung

  • Scientific and Innovative Action Plan of Shanghai
  • National Natural Science Foundation of China

Zitieren

APA

Song, X., Wu, Y., Qu, X., & Jiang, B. (2023). Applications of macrocyclic molecules in cancer therapy: Target cancer development or overcome drug resistance. MedComm – Oncology, 2(3). https://doi.org/10.1002/mog2.50

Vancouver

Song X, Wu Y, Qu X, Jiang B. Applications of macrocyclic molecules in cancer therapy: Target cancer development or overcome drug resistance. MedComm – Oncology. 2023;2(3). doi:10.1002/mog2.50

BibTeX
@article{Song2023,
  author = {Song, Xiaoling and Wu, Yifan and Qu, Xiaojuan and Jiang, Biao},
  title = {Applications of macrocyclic molecules in cancer therapy: Target cancer development or overcome drug resistance},
  journal = {MedComm – Oncology},
  year = {2023},
  volume = {2},
  number = {3},
  doi = {10.1002/mog2.50}
}
Kostenlos starten →